𝐒 𝐉 π„π—πˆπŒ π’πžπ«π―π’πœπžπ¬

Hello, I’m Shubhra.

CEO-Shubhra Jha

Welcome to SJ EXIM Services. We are a niche consulting firm specializing in highly targeted solutions for Indirect Tax, Customs, Arbitration, and Customs Compliance Advisory across India. No matter where your business operates, our specialized expertise is available on a pan-India basis since August 2015.
Let’s craft a custom solution for you. Connect with us via email below.

CDSCO

Dated: 03.04.2025

The Central Drugs Standard Control Organization (CDSCO), under the Ministry of Health and Family Welfare, has released a significant draft notification updating the risk-based classification of cardiovascular medical devices. This update, effective from 1st April 2025, aligns with the provisions of the Medical Devices Rules, 2017, and seeks to ensure enhanced regulatory oversight and patient safety.

Objective of the Update

The revised classification list includes 351 cardiovascular devices, each assigned a risk class based on its intended use, level of invasiveness, and interaction with the cardiovascular system. This move aims to:

  • Align Indian regulatory standards with global benchmarks.
  • Facilitate clear regulatory pathways for manufacturers.
  • Enhance safety and efficacy standards for medical devices.

Highlights of the Risk Classification

The classification is structured across four risk categories:

  • Class A: Low risk
  • Class B: Low to moderate risk
  • Class C: Moderate to high risk
  • Class D: High risk

Examples from the list include:

  • Class D: Aortic valve prostheses, Implantable pacemakers, Implantable cardioverter defibrillators, Cardiopulmonary bypass systems.
  • Class C: Extracorporeal membrane oxygenation (ECMO) systems, Cardiac mapping systems, Cardiac monitors.
  • Class B: Manual and digital sphygmomanometers, Home-use ECG monitors, Ambulatory blood pressure monitors.

Each device is listed with a unique serial number and assigned its appropriate risk classification.

Timeline and Implementation

  • Effective Date: 1st April 2025
  • The classification will apply to all cardiovascular medical devices imported, manufactured, or sold in India.

Stakeholder Engagement

CDSCO has invited feedback from stakeholders, including manufacturers, healthcare professionals, industry associations, and consumers.

  • Comments and suggestions are to be submitted within 30 days from the date of the notification.
  • A dedicated Google Form has been made available for this purpose: Submit Feedback Here

Implications for the Industry

  • Manufacturers must ensure their devices are classified correctly and comply with applicable regulatory requirements.
  • Devices falling under Class C and D will be subject to stricter conformity assessment procedures.
  • The update promotes a more transparent, predictable, and safety-focused regulatory environment for cardiovascular devices.

In case you face any issues related to Indirect Tax-Customs, GST, Foreign Trade Policy (FTP), Arbitration matters and Central Licensing and related advisory matters in India then please feel free to get in touch with SJ EXIM Services.

We offer Legal advice and litigation support in matters related to Indirect Tax-Customs, FTP, other Indirect Tax matters & Arbitration law, all sorts of Central licensing and related matters. Come and explore the new way of doing business with us!

1. The views expressed are based on the interpretation of the relevant information/documents, applicable law, and government policy and there is no assurance that a court or tribunal or regulatory body or other governmental authority may not interpret it differently.
2.  We are not responsible for updating or revising this article on account of any change in law or interpretation thereof or a change in events or circumstances informed or occurring after the date of this article unless specifically requested for it.
3. Our advice should not be taken or used out of context or reproduced for any other purpose or transaction. Views expressed in this update are strictly personal, based on our understanding of the underlying law.
4. We are not responsible for any injury, loss or cost arising to any person who refers to this update and acts or refrains from any act accordingly. We would suggest that detailed legal advice must be sought before relying on this update.

NOTE: All Inquiries/Consulting/Advisory/Assignments are solicited via email only & it is a PAID Service only!


Discover more from 𝐒 𝐉 π„π—πˆπŒ π’πžπ«π―π’πœπžπ¬

Subscribe to get the latest posts sent to your email.

Leave a Reply

Let’s connect

← Back

Thank you for your response. ✨

Discover more from 𝐒 𝐉 π„π—πˆπŒ π’πžπ«π―π’πœπžπ¬

Subscribe now to keep reading and get access to the full archive.

Continue reading

Discover more from 𝐒 𝐉 π„π—πˆπŒ π’πžπ«π―π’πœπžπ¬

Subscribe now to keep reading and get access to the full archive.

Continue reading